Navigation Links
PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,,,Demonstrate Safety and Efficacy at Once-Weekly Dosing

od glucose levels."

ConjuChem intends to submit the study results for presentation at a scientific meeting in 2007.

In conjunction with the multi-dose results, ConjuChem also reported that ongoing product development programs including manufacturing process improvements are expected to be completed in 2007 in time to be included in a Phase II study, which is planned for initiation by year-end.

About PC-DAC(TM):Exendin-4

Exendin-4 is a Glucagon-like peptide-1 (GLP-1) homolog and an agonist for the GLP-1 receptor. Exendin-4 decreases glucagon and increases insulin secretion in a glucose-dependent manner. Exendin-4 may stimulate beta-cell proliferation, restore beta-cell sensitivity to glucose, delay gastric emptying, and increase peripheral sensitivity to glucose. The clinical utility of Exendin-4 is somewhat limited by its relatively short half-life in plasma. Developed with ConjuChem's proprietary PC-DAC(TM) technology, PC-DAC(TM):Exendin-4 is a modified Exendin-4 analogue that is covalently bound to recombinant human albumin (Recombumin(R), provided by Novozymes Delta Limited). The preformed albumin-peptide conjugate has a much longer half-life than the peptide alone. The product is a highly soluble liquid formulation that is injectable in a small volume with a small gauge needle.

Conference Call

The Company will be hosting a conference call with management to discuss these results on Tuesday, March 27, 2007 at 8:30 a.m. EDT. The call will be audio-cast live and archived for 90 days at www.conjuchem.com. A taped replay of the call will be available by telephone on March 27, 2007 through Tuesday, April 3rd, 2007 at midnight. To access the replay, dial 416-640-1917 or 877-289-8525 and enter access code 21224642.

About ConjuChem

ConjuChem, developer of next generation medicines from therapeu
'"/>




Page: 1 2 3 4

Related medicine technology :

1. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:
(Date:11/20/2009)..., , NEW YORK, Nov. 20 ...t research report is available in its catalogue. ,...Forecasts to 2015 ,, http://www.reportlinker...sis-and-Forecasts-to-2015.html#utm_source=prnewswi... ,, Description ,, India Medical Equipment...
(Date:11/20/2009)..., , MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCa...unced results for its first quarter ended Septembe... per diluted share, on revenues of $3,263,000. Th...per diluted share, on revenues of $3,168,000 for t... the first quarter results, Biotel President and C...
(Date:11/20/2009)..., , PRINCETON, N.J., Nov. 20 /PRNewswire-... SNGX) (Soligenix or the Company), formerly known ... company, announced today that it has formed a con...nce RiVax(TM) and other rapidly acting vaccines. S...tional Institute of Allergy and Infectious Disease...
Breaking Medicine Technology:Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Biotel Announced Profitable First Quarter Ended September 30, 2009 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 1Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 3Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 4Team Full Throttle Twinlab 28R 29 Racing Nabs Podiums in Several Divisions at the 2009 Robert J Aaron Memorial Mighty Montauk Triathlon 49915 1Team Full Throttle Twinlab 28R 29 Racing Nabs Podiums in Several Divisions at the 2009 Robert J Aaron Memorial Mighty Montauk Triathlon 49915 2Greenway Medical Technologies Supports Community Based Interoperability Efforts by Offering Preferred Rates to Buffalo N Y Area Community Healthcare 49912 1Greenway Medical Technologies Supports Community Based Interoperability Efforts by Offering Preferred Rates to Buffalo N Y Area Community Healthcare 49912 2Greenway Medical Technologies Supports Community Based Interoperability Efforts by Offering Preferred Rates to Buffalo N Y Area Community Healthcare 49912 3
..., 2007--The World Health Organization,has released... in,Pakistan. , So is this another instance where,...tical industry is denying important vaccines to,po...o London’s Guardian,newspaper, “parent...to allow health workers to administer polio vaccin...
...-Mar 8, 2007 - Vaxiion Therapeutics,Inc. today an...h,San Diego State University, have discovered a ,m...l to protect against several,disease-causing infec...e online edition of,the journal, Vaccine, and the ... , While most vaccines contain live micro-organism...
Other Medicine Technology:Why Is Polio Spreading in Pakistan? 2Vaxiion Researchers Discover Novel Vaccine Delivery System in,Collaboration with San Diego State University 2
(Date:11/22/2009).... November 18, 2009 -- When people have malaria, t...enter the body from the saliva of a mosquito, infe...d cells. Inside the blood cells, the parasites rep...on the cell surface that change the physical natur... show that infected red blood cells are stiffer an...
(Date:11/22/2009)...help keep eating under control, expert says , ...liday season means you,ll be faced with a seemingl...ople simply give in and eat too much, others deny ...ways to navigate between overindulgence and depriv...ition Consult Services at Brigham and Women,s Hosp...
(Date:11/22/2009)...N, Nov. 21 Congressman ... upon the United States Senate,s vote tonight to p...tion: ,, "Senators Arlen Specter and Bob Casey ...ylvanians for casting stand-up, critical votes in ...toric Affordable Health Care Reform legislation to...
(Date:11/21/2009)...K, Nov. 21 Milvia Lopez, by her at...recently filed suit, in Supreme Court, New York Co...lleges that while Ms. Lopez underwent a routine tr...NT,S HOSPITAL , doctors used an HIV infected scope...s that several hours after being discharged from t...
(Date:11/21/2009)... NH based medical credentialing software com...y to form a partnerhsip with Amerinet, Inc., the l...ship will help to transform quality care within th...ocus) November 21, 2009 -- ISG Group, LLC, doing b...agreement with Amerinet Inc., a leading national h...
Breaking Medicine News(10 mins):Health News:Measuring and modeling blood flow in malaria 2Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2
...rance, since her arrest for causing the death of f...that neither she nor// the two co-accused nurses, ...eled against them by the Louisiana Attorney Genera...at Dr.Pou along with the two nurses had equipped t...
...gh pollution levels can increase people’s suscepti...apan have found that the risk of stroke from pollu...ently breathing and heart problems are associated ... and Environmental Medicine. The researchers colle...
... approved a virus mix in spray form that kills bac...n last month.// Processed meats after being...ia. The approved spray is a combination of viruses...t E. Coli or Salmonella, other potential fatal ora...
...s’ poor training is resulting in unnecessary emerg...s have reported in this// week’s British Medical J... several emergency Caesareans. Currently, in... by trainees. Experts revealed that there were "su...
...t will increase the money spent on AIDS in the Sou...s said that// increased spending was needed since ...reading. "It shouldn't matter where you live...ee. "I don't think that's right." The Ryan W...
...to outsource medical transcription to India have v...// Several hospitals in Britain have outsourc...f typing up patients' notes to India to save costs...s, staff has voted for industrial action if manage...
Other Medicine News:Health News:Stroke Linked to High Pollution Levels 2Health News:Skilled Obstetricians to avoid unnecessary Caesareans 2Health News:Britain Hospital Staff Threatens Strike 2
Epiretinal Membrane Dissector
Silicone Oil Removal Kit
Vitreoretinal Micro Cannula
Fox Eye Shield - 50 per box
Medicine Products: